283
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study

ORCID Icon, , , , , & show all
Pages 85-94 | Received 24 Nov 2020, Accepted 25 Mar 2021, Published online: 27 Mar 2021

References

  • Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens 2019;45:11–18.
  • Fechtner RD, Godfrey DG, Budenz D, Stewart JA, et al. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010;29:618–621.
  • Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 2004;23:490–496.
  • Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res 2015;49:17–45.
  • Le Q, Xu J, Deng SX. The diagnosis of limbal stem cell deficiency. Ocul Surf 2018;16:58–69.
  • Sun Y, Yung M, Huang L, et al. Limbal stem cell deficiency after glaucoma surgery. Cornea 2020;39:566–572.
  • Deng SX, Borderie V, Chan CC, et al. Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency. Cornea 2019;38:364–375.
  • Mehtani A, Agarwal MC, Sharma S, Chaudhary S. Diagnosis of limbal stem cell deficiency based on corneal epithelial thickness measured on anterior segment optical coherence tomography. Indian J Ophthalmol 2017;65:1120–1126.
  • Dua HS, Shanmuganathan VA, Powell-Richards AO, et al. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol 2005;89:529–532.
  • Feng Y, Simpson TL. Corneal, limbal, and conjunctival epithelial thickness from optical coherence tomography. Optom Vis Sci 2008;85:E880–E883.
  • Liang Q, Le Q, Cordova DW, et al. Corneal epithelial thickness measured using AS-OCT as a diagnostic parameter for limbal stem cell deficiency. Am J Ophthalmol 2020;216:132–139.
  • Chan EH, Chen L, Yu F, Deng SX. Epithelial thinning in limbal stem cell deficiency. Am J Ophthalmol. 2015;160:669.e4–677.e4.
  • Banayan N, Georgeon C, Grieve K, Borderie VM. Spectral-domain optical coherence tomography in limbal stem cell deficiency. A case-control study. Am J Ophthalmol 2018;190:179–190.
  • Muthusamy K, Tuft SJ. Iatrogenic limbal stem cell deficiency following drainage surgery for glaucoma. Can J Ophthalmol 2018;53:574–579.
  • Bhattacharya P, Edwards K, Harkin D, Schmid KL. Central corneal basal cell density and nerve parameters in ocular surface disease and limbal stem cell deficiency: a review and meta-analysis. Br J Ophthalmol. 2020;104(12):1633–1639.
  • Guarnieri A, Carnero E, Bleau AM, et al. Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients. Int Ophthalmol 2020;40:741–751.
  • Mathews PM, Ramulu PY, Friedman DS, et al. Evaluation of ocular surface disease in patients with glaucoma. Ophthalmology 2013;120:2241–2248.
  • Pérez-Bartolomé F, Martínez-de-la-Casa JM, Arriola-Villalobos P, et al. Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol 2017;27:694–704.
  • Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol 2012;153:1–9.e2.
  • Saade CE, Lari HB, Berezina TL, et al. Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study. Can J Ophthalmol 2015;50:132–136.
  • Saini M, Vanathi M, Dada T, et al. Ocular surface evaluation in eyes with chronic glaucoma on long term topical antiglaucoma therapy. Int J Ophthalmol 2017;10:931–938.
  • Valente C, Iester M, Corsi E, Rolando M. Symptoms and signs of tear film dysfunction in glaucomatous patients. J Ocul Pharmacol Ther 2011;27:281–285.
  • Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, et al. Meibomian gland dysfunction in patients receiving long-term glaucoma medications. Cornea 2016;35:1112–1116.
  • Arita R, Itoh K, Maeda S, et al. Effects of long-term topical anti-glaucoma medications on meibomian glandsGraefes. Graefes Arch Clin Exp Ophthalmol 2012;250:1181–1185.
  • Martone G, Frezzotti P, Tosi GM, et al. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol 2009;147:725–735.e1.
  • Wong TT, Aung T, Ho CL. Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride. Clin Experiment Ophthalmol 2018;46:1028–1034.
  • Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 1998;82:39–42.
  • Schwartz GS, Holland EJ. Iatrogenic limbal stem cell deficiency. Cornea 1998;17:31–37.
  • Mastropasqua L, Agnifili L, Mastropasqua R, et al. In vivo laser scanning confocal microscopy of the ocular surface in glaucoma. Microsc Microanal 2014;20:879–894.
  • Mastropasqua R, Agnifili L, Fasanella V, et al. Corneoscleral limbus in glaucoma patients: in vivo confocal microscopy and immunocytological study. Invest Ophthalmol Vis Sci 2015;56:2050–2058.
  • Pauly A, Roubeix C, Liang H, et al. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Invest Ophthalmol Vis Sci 2012;53:8172–8180.
  • Zhivov A, Kraak R, Bergter H, et al. Influence of benzalkonium chloride on langerhans cells in corneal epithelium and development of dry eye in healthy volunteers. Curr Eye Res 2010;35:762–769.
  • Haagdorens M, Behaegel J, Rozema J, et al. A method for quantifying limbal stem cell niches using OCT imaging. Br J Ophthalmol 2017;101:1250–1255.
  • Bizheva K, Hutchings N, Sorbara L, et al. In vivo volumetric imaging of the human corneo-scleral limbus with spectral domain OCT. Biomed Opt Express 2011;2:1794–1702.
  • Francoz M, Karamoko I, Baudouin C, Labbe A. Ocular surface ’ epithelial thickness evaluation with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:9116–9912.
  • Haque S, Jones L, Simpson T. Thickness mapping of the cornea and epithelium using optical coherence tomography. Optom Vis Sci 2008;85:E963–E976.
  • Batawi H, Lollett IV, Maliakal C, et al. A comparative study of central corneal epithelial, stromal, and total thickness in males with and without primary open-angle glaucoma. Cornea 2018;37:712–719.
  • Cennamo G, Montorio D, Del Prete S, et al. Anterior-segment optical coherence tomography and scanning electron microscopy to evaluate corneal epithelial changes in patients undergoing glaucoma therapy. Cornea 2018;37:1522–1526.
  • Maldonado MJ, Ruiz-Oblitas L, Munuera JM, et al. Optical coherence tomography evaluation of the corneal cap and stromal bed features after laser in situ keratomileusis for high myopia and astigmatism. Ophthalmology 2000;107:81–87.
  • Mastropasqua L, Agnifili L, Mastropasqua R, Fasanella V. Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma. Curr Opin Pharmacol 2013;13:56–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.